Pharmacy Pearls: GLP-1 RAs for Weight Loss

Home › News › Pharmacy Pearls: GLP-1 RAs for Weight Loss

Pharmacy Pearls: GLP-1 RAs for Weight Loss

September 2nd, 2021 | Pharmacy Pearls•Diabetes

This edition of Pharmacy Pearls reviews some of the evidence supporting the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss, including a review of the newest approved product, Wegovy (semaglutide). There is also a comparison to a select list of other currently-approved weight loss agents relative to average weight loss and expected side effects. Email the Pharmacy Team with any questions or feedback you may have.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download PDF [245.96 KB]

135 Corporate Woods, Suite 320
Rochester, New York 14623-1466

Phone: (585) 758-7823
Fax: (585) 424-1268

Listings

Member Benefits

FAQs

About Us

© Copyright - Accountable Health Partners - 2024

Website by:  Accelerate Media

This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP).  An offer will only be made by means of a confidential private placement memorandum and subscription agreement.